Jorg Hanrieder

Gower Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer's disease models.

Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer's disease models.

Journal: Science translational medicine

Published: February 11, 2026

Considerations for Spatial Omics, Metabolite Analyses, and Tissue-Harvesting Artifacts.

Considerations for Spatial Omics, Metabolite Analyses, and Tissue-Harvesting Artifacts.

Journal: Journal of neurochemistry

Published: October 21, 2025

Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP.

Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP.

Journal: Acta neuropathologica

Published: October 13, 2025

Saliva phosphorylated tau concentration is not associated with Alzheimer's disease, cerebrospinal fluid or blood biomarkers.

Saliva phosphorylated tau concentration is not associated with Alzheimer's disease, cerebrospinal fluid or blood biomarkers.

Journal: Frontiers in neuroscience

Published: October 03, 2025

Nanotip acetylcholine biosensor reveals cholinergic differentiated SH-SY5Y cells release partial vesicle content during exocytosis.

Nanotip acetylcholine biosensor reveals cholinergic differentiated SH-SY5Y cells release partial vesicle content during exocytosis.

Journal: Bioelectrochemistry (Amsterdam, Netherlands)

Published: September 30, 2025

The Uppsala APP Mutation Promotes Wild-Type Amyloid-β Aggregation and Deposition In Vivo.

The Uppsala APP Mutation Promotes Wild-Type Amyloid-β Aggregation and Deposition In Vivo.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 28, 2025

Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain-Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease.

Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain-Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease.

Journal: Journal of neurochemistry

Published: July 16, 2025

Electrochemical Droplet Sculpturing of Short Carbon Fiber Nanotip Electrodes for Neurotransmitter Detection.

Electrochemical Droplet Sculpturing of Short Carbon Fiber Nanotip Electrodes for Neurotransmitter Detection.

Journal: ACS electrochemistry

Published: April 04, 2025

Isotope Encoded Spatial Biology Identifies Amyloid Plaque-Age-Dependent Structural Maturation, Synaptic Loss, and Increased Toxicity.

Isotope Encoded Spatial Biology Identifies Amyloid Plaque-Age-Dependent Structural Maturation, Synaptic Loss, and Increased Toxicity.

Journal: Research square

Published: February 20, 2025

Isotope-encoded spatial biology identifies plaque-age-dependent maturation and synaptic loss in an Alzheimer's disease mouse model.

Isotope-encoded spatial biology identifies plaque-age-dependent maturation and synaptic loss in an Alzheimer's disease mouse model.

Journal: Nature communications

Published: January 14, 2025

Age- and amyloid-β-dependent initiation of neurofibrillary tau tangles: an improved mouse model of Alzheimer's disease without mutations in MAPT.

Age- and amyloid-β-dependent initiation of neurofibrillary tau tangles: an improved mouse model of Alzheimer's disease without mutations in MAPT.

Journal: bioRxiv : the preprint server for biology

Published: November 22, 2024

Levetiracetam prevents Aβ42 production through SV2a-dependent modulation of App processing in Alzheimer's disease models.

Levetiracetam prevents Aβ42 production through SV2a-dependent modulation of App processing in Alzheimer's disease models.

Journal: bioRxiv : the preprint server for biology

Published: November 18, 2024

Showing 1-12 of 76

Last Updated: 09/26/2026